Company Overview

Development Stage

About the Company

[Summary] A large traditional Chinese medicine enterprise integrating R&D, produ

Jiangsu Kanion Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine (TCM) enterprise integrating R&D, production, and trade. It is an A-share listed company, recognized as a national key high-tech enterprise, a national innovative pilot enterprise, a national technology innovation demonstration enterprise, a national intellectual property demonstration enterprise, and one of the top 100 Chinese pharmaceutical enterprises (29th). It has established research platforms such as the State Key Laboratory of New Technology for Pharmaceutical Manufacturing of Traditional Chinese Medicine and the National-Local Joint Engineering Research Center for Intelligent Manufacturing of Chinese Patent Medicines. It is one of the Chinese herbal medicine companies with the most new drug certificates and invention patents, and one of the deepest promoters of TCM internationalization.
Kanion Pharmaceutical adheres to institutional and technological innovation, having established a comprehensive Jiangsu Kanion Modern Chinese Medicine Research Institute, with a scientific research team of nearly 500 people, over 70% of whom hold master's or doctoral degrees. To date, it has launched more than 50 modern TCM new drugs, including Guizhi Fuling Capsules, Reduning Injection, Jinzhen Oral Liquid, and Ginkgo Diterpene Lactone Meglumine Injection, which have become well-known brands in gynecological and anti-infective treatment fields. It has undertaken over 50 national science and technology projects, including "973" and "863" projects, international cooperation projects, and major new drug innovation projects, holds nearly 500 authorized invention patents, and has won two second prizes of the National Science and Technology Progress Award, one second prize of the National Technology Invention Award, eight first prizes of provincial and ministerial science and technology progress awards, and two China Patent Gold Awards. It has built China's intelligent TCM production factory, which is a smart manufacturing pilot demonstration project approved by the Ministry of Industry and Information Technology. The TCM intelligent solid preparation factory, upon completion, will fully realize automated, informational, and intelligent control of the entire process from extraction and purification of TCM raw materials to preparation, with strong industry demonstration effect.
Looking to the future, the company will adhere to the core concept of "Premium Chinese Medicine, Created by Kanion," vigorously develop modern TCM, promote its internationalization, steadily expand the broader TCM industry and biopharmaceutical industry, and make greater contributions to high-quality industrial development and human health.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Kanion Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Kanion Pharmaceutical How Fast Is Hiring Growing? (1053 open positions)

Manage
Note: How fast is hiring at Jiangsu Kanion Pharmaceutical Co., Ltd. growing? Kanion Pharmaceutical2025: 1957 openings (up 57%), 2024: 1243 openings (up 167%), 2023: 465 openings (up 489%), 2022: 79 openings (down 83%), 2021: 458 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Kanion Pharmaceutical Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Jiangsu Kanion Pharmaceutical Co., Ltd. growing? Kanion PharmaceuticalMaster's recruitment over the years: 2025: 66 openings (down 28%), 2024: 92 openings (up 114%), 2023: 43 openings (up 514%), 2022: 7 openings (down 59%), 2021: 17 openings.

Kanion Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
-29%
Growth Rate
2026 vs 2025
  • 2025: Down 36%
  • 2024: Up 175%
Kanion Pharmaceutical Doctoral Hiring by Year: 2026 — 4 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Jiangsu Kanion Pharmaceutical Co., Ltd. growing? Kanion PharmaceuticalDoctorate recruitment over the years: 2026: 10 openings (down 29%), 2025: 14 openings (down 36%), 2024: 22 openings (up 175%), 2023: 8 openings.

Kanion Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Jiangsu Kanion Pharmaceutical Co., Ltd.? Based on an analysis of Kanion Pharmaceutical's job postings over the past year, "医疗卫生/美容保健类" demand: 7.1%, "计算机/网络/技术类": 6%, "生物/制药/化工/环保类": 1.6%, "其他(研发和技术类)": 0.8%, "美术/设计/创意类": 0.8%, "科研类": 0.6%. For reference only.

Kanion Pharmaceutical — What Are the Salaries Like? (2434 records)

Manage
Kanion Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 56.1% of roles pay ¥6-10K
Note: salary statistics are based on 2434 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Jiangsu Kanion Pharmaceutical Co., Ltd.?Kanion Pharmaceutical56.1% of positions earn 6-10K, Fresh graduate salary: ¥7.8K。Lianyungang salary ranking top 25,销售类 average salary ¥11.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Kanion Pharmaceutical

(More)
Are salaries high at Jiangsu Kanion Pharmaceutical Co., Ltd.? We provide: 医药代表,信息,推广,招商,销售,省区经理,公司经理,运营,临床,产品经理,地区经理,otc代表,bp,客户经理,零售,处经理,会计,ka,渠道,地区主管. Click to view detailed salary analysis by job.

Kanion Pharmaceutical — Fortune 500? (More)

Kanion Pharmaceutical Related Industry Tags

Job Category

  • 销售类
    64% of total 64%
  • 经营管理类
    19.1% of total 19.1%
  • 市场/公关/媒介类
    12.5% of total 12.5%
  • 医疗卫生/美容保健类
    7.5% of total 7.5%

Education

  • 本科
    47.6% of total 47.6%
  • 大专
    44.4% of total 44.4%
  • 硕士
    5.9% of total 5.9%
  • 不限
    1.6% of total 1.6%

Experience

  • 1-3年
    50.1% of total 50.1%
  • 不限
    21.4% of total 21.4%
  • 3-5年
    20.8% of total 20.8%
  • 5-10年
    5.9% of total 5.9%
View Detailed Analysis

What does Jiangsu Kanion Pharmaceutical Co., Ltd. require? Who is Kanion Pharmaceutical hiring? Kanion Pharmaceutical recruitment: 销售类占比最多占64%,其次是经营管理类占19.1%. What education can get in at Kanion Pharmaceutical? 本科占比最多占47.6%,其次是大专占44.4%. High education required at Kanion Pharmaceutical? 硕士占5.9%,博士占0.4%. Work experience required at Kanion Pharmaceutical? 1-3年占比最多占50.1%,其次是不限占21.4%. Where are the job locations at Kanion Pharmaceutical? 南京占比最多占17.2%,其次是连云港占7.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 56,615.8806万(元)
Legal Representative: 高海鑫
Date Established:
Credit Code: 91320700138997640W
Registered Address: 连云港经济技术开发区江宁工业城

Partners & Suppliers

广安门医院采购康缘药业的中药注射液等产品,并合作开展临床研究。 Source
合作客户 中成药供应商
作为公司主要经销商,采购公司中成药产品进行华东等重点区域分销 Source
合作客户 医药商业/分销
作为公司主要经销商,采购公司中成药产品进行全国分销 Source
合作客户 医药商业/分销
作为公司主要经销商,采购公司中成药产品进行全国分销 Source
合作客户 医药商业/分销
代理桂枝茯苓胶囊等妇科中成药,负责山东医疗机构推广 Source
合作客户 中成药

People who follow Kanion Pharmaceutical also follow

Kanion Pharmaceutical Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Seek and strive, protect and heal all beings”
“R&D and production of anti-tumor and psychotropic drugs, ranked among ”
“To develop high-quality biologics that are accessible and affordable f”
“Mainly engaged in the production and sales of antibiotics, traditional”
“Health for Humanity, Creating a Better Future Together”
医药 生物医药 医药工业 大健康
“Peptides, chemical and biological APIs and preparations”
“A large private modern pharmaceutical distribution enterprise in China”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“One of China's Top 20 Listed Pharmaceutical Companies”
医药 工程技术 制药工程 医药工业
“Products for the diagnosis and treatment of allergic diseases”
制药/药业 中成药 医药 药物研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates